[HTML][HTML] An update on molecular biology of cutaneous T cell lymphoma

R Walia, CCS Yeung - Frontiers in oncology, 2020 - frontiersin.org
R Walia, CCS Yeung
Frontiers in oncology, 2020frontiersin.org
Cutaneous T cell lymphomas represent a heterogenous group of lymphoproliferative
disorders defined by clonal proliferation of T cells present in the skin. The latest WHO
classification in 2016 and WHO-EORTC classification in 2018 has updated the classification
of these entities based on the molecular profile. Research in the field of molecular genetics
of CTCL has allowed a better understanding of the biology of these tumors and has helped
to identify potential targets for therapy that can be tailored to individual patients. In this …
Cutaneous T cell lymphomas represent a heterogenous group of lymphoproliferative disorders defined by clonal proliferation of T cells present in the skin. The latest WHO classification in 2016 and WHO-EORTC classification in 2018 has updated the classification of these entities based on the molecular profile. Research in the field of molecular genetics of CTCL has allowed a better understanding of the biology of these tumors and has helped to identify potential targets for therapy that can be tailored to individual patients. In this review, we discuss the latest developments in the molecular profile of CTCLs including biomarkers for diagnosis, prognosis, and potential therapeutic targets. We have also touched upon the utility of various molecular diagnostic modalities. For the purpose of this review, we researched papers in PubMed indexed journals in English literature published in the past 20 years using keywords CTCL, mycosis fungoides, molecular profile, molecular diagnosis, whole genome profile, genomic landscape, TCR clonality.
Frontiers